Piramal Enterprises’ arm approves acquisition of CCPL from Navin Fluorine International

29 Oct 2020 Evaluate

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has approved the acquisition of additional 3,43,04,900 equity shares of the face value of Rs 10 each of Convergence Chemicals (CCPL) for an aggregate cash consideration of Rs 65.10 crore from Navin Fluorine International. Consequent to this Acquisition, CCPL would become a wholly owned subsidiary of PPL. The Acquisition is likely to be completed by January 31, 2021.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 919.55
Shriram Finance 995.25
Aditya Birla Capital 347.55
Chola Invest & Fin. 1641.60
Tata Capital 342.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×